Drug application
BACITRACIN ZINC-POLYMYXIN B SULFATE (BACITRACIN ZINC, POLYMYXIN B SULFATE)
Drugs@FDA ANDA 062849 · NASKA
Key facts
| Drug name | BACITRACIN ZINC-POLYMYXIN B SULFATE |
|---|---|
| Active ingredients | BACITRACIN ZINC, POLYMYXIN B SULFATE |
| Application type | ANDA |
| Application number | 062849 |
| Company | NASKA |
| Dosage forms | OINTMENT, TOPICAL |
| Strength | 500 UNITS/GM;10,000 UNITS/GM |
| Marketing status | Discontinued |
| Reference listed drug | No |
At a glance
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.